Tag: Synavir Corporation
-
Rutgers leading coronavirus therapeutic clinical trial that focuses on cases with mild symptoms
Researchers are investigating a potential treatment for people recently diagnosed with SARS-CoV-2 who have no or mild symptoms Rutgers is leading a clinical trial assessing the combination of nitazoxanide, ribavirin and hydroxychloroquine to treat people 21 or older who are infected with SARS-CoV-2 and are asymptomatic or mildly symptomatic. The trial is being conducted…
